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ABSTRACT
Cardiac computerized tomography (CT) has
evolved from a research tool to an important
diagnostic investigation in cardiology, and is
now recommended in European, US, and UK
guidelines. This review is designed to give the
reader an overview of the current state of
cardiac CT. The role of cardiac CT is
multifaceted, and includes risk stratification,
disease detection, coronary plaque
quantification, defining congenital heart
disease, planning for structural intervention,
and, more recently, assessment of ischemia.
This paper addresses basic principles as well as
newer evidence.
Keywords: Calcium score; Cardiac
computerized tomography; Computerized
tomography coronary angiography; Plaque
characteristic analysis
INTRODUCTION
In the modern era, cardiac computerized
tomography (CT) provides a robust
non-invasive assessment of coronary artery
disease (CAD) with a high degree of accuracy
[1, 2]. It is capable of providing anatomical
information about plaque stenosis and
composition, and is now recommended in
national guidelines [3–5]. Its beginnings,
however, were humble, and mainly of an
exploratory nature. The evolution of cardiac
CT is directly proportional to the growing
clinical demand for better imaging and the
technological improvements seen with
successive generations of scanners. This
continuous evolution has now enabled
coronary assessment with a high degree of
accuracy at low levels of radiation for both
acute and stable lesions [6, 7].
The invention of the CT scanner in 1971 is
credited to Sir Godfrey Hounsfield, an English
engineer, and Dr. Allan Cormack, a South
African physicist, with the first human CT
performed on a patient’s brain in London in
1972 [8]. The original scanner is preserved in
the British Museum in London (Fig. 1). Eight
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years after their invention, Hounsfield and
Cormack were jointly awarded the Nobel Prize
in Physiology or Medicine. Since then, the use
of CT has expanded dramatically to include
many organs, eventually incorporating the
heart, first with coronary calcium scores (CS)
and then coronary CT angiography (CTA). This
paper illustrates the history of cardiac CT, from
its beginnings as a research tool, and coming to
fruition as an essential diagnostic cardiac
investigation. It also addresses several key
principles of cardiac CT and highlights future
directions. This article is based on previously
conducted studies and does not involve any
new studies of human or animal subjects
performed by any of the authors.
CORONARY CALCIUM SCORE
Coronary artery calcium, as seen in established
coronary atherosclerosis, results from the
buildup of substances over time which have
hardened and become calcified. The histological
atherosclerotic process was classified by Stary
et al. [9] in 1995, with calcification involved in
the later stages. The presence of calcium
suggests established CAD, with the CS
calculating the total amount of coronary
artery calcified plaque present collectively
within all the coronary arteries. The first
report regarding the ability of CT to measure
CS was published by Guthaner et al. [10] in
1979, although it was Agatston et al. [11] in
1990 who introduced a practical application of
CS. The technique proposed by Agatston for
producing a standardized reproducible score has
remained the standard method to the present
day. The Agatston score is calculated using both
the area and a weighted value related to the
density of calcification. Any structure with a
density greater than 130 Hounsfield units (HU)
and with an area of 1 mm2 or greater is
quantified as a calcified focus. Foci within the
anatomic site of coronary arteries represent
calcified CAD plaques. The minimum area of
1 mm2 (comprising at least 2 pixels) required to
be counted as part of the CS ensures that a
single pixel, which could represent image noise,
would not be counted. The area of foci is then
multiplied by a density measurement
conversion factor. A score of 1 is assigned for a
value of 130–199 HU, a score of 2 for 200–299
HU, 3 for 300–399 HU, and 4 for values of 400
HU and higher. The weighted score is then
multiplied by the area of the coronary
calcification to calculate the Agatston score.
A CS is obtained using a non-enhanced scan
that produces a series of stacked transaxial
images, which is associated with relatively low
radiation exposure [12, 13]. Agatston scores are
now calculated using a semi-automated
analysis package validated algorithm. Figure 2
highlights the presence of coronary calcification
within the left anterior descending artery.
Guidelines have suggested that absolute values
above 400 HU are high enough to warrant
invasive angiography [3, 4]. Numerous studies
have highlighted the link between high CS, the
presence of significant CAD stenosis, and the
Fig. 1 The ﬁrst computed tomography scanner, British
Museum, London
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risk of future cardiovascular events [14–17]. A
strong link has also been shown between CS
and both regional left ventricular wall motion
abnormalities and active ischemia [18, 19].
The CS has also been used extensively in
asymptomatic screening, and has been
incorporated into US guidelines as the tool of
choice for absolute CAD risk assessment in
asymptomatic adults [20]. Studies have shown
that a CS of zero in asymptomatic patients
indicates an excellent prognosis, regardless of
traditional risk factors [21, 22]. The absence of
calcium seems to confer reasonable longevity of
protection against the risk of CAD, with
previous research reporting approximately
80% of patients still having a score of zero at
4–5 years, although 1% had scores [100 [23].
Asymptomatic individuals with a CS of zero
were found to be at very low risk of future
cardiovascular events (\1%), whereas the risk of
a CAD event was threefold greater among those
with a minimal CS (1–10) [24]. As such, some
have claimed that a CS of zero is the most
powerful negative risk factor for near- and
medium-term development of coronary events
among asymptomatic adults [25]. Results of the
large Multi-Ethnic Study of Atherosclerosis
(MESA) trial have suggested that a doubling of
CS over time increased the estimated
probability of coronary events by
approximately 25% [26].
Although the CS reflects the coronary
atherosclerotic plaque burden, the absence of
calcification does not completely rule out
obstructive CAD. Non-calcified potentially
vulnerable plaque will not be identified with
the use of the CS [27]. The incidence of
significant CAD in the absence of calcium
seems to be dependent on factors of ethnicity,
age, and presentation [28], but has been quoted
around 2–5% [29, 30]. In the absence of calcium
but in the case of clinical concern, as
demonstrated through clinical prediction
scores, the use of coronary CTA may still be
necessary for the assessment of non-calcified
atherosclerotic plaques and the degree of
coronary stenosis [31].
COMPUTERIZED TOMOGRAPHY
CORONARY ANGIOGRAPHY
In the 1970s, attempts were made to image
coronary arteries using CT, but the effects of
rapid cardiac motion and long acquisition times
resulted in images of poor quality, with no
practical value. In the 1980s, the detection of
coronary arteries was possible, but the
identification of stenosis for clinical purposes
was not [32, 33]. Consequently, cardiac coronary
CTA was virtually abandoned for a long period,
and was seen as nothing more than a research
Fig. 2 Coronary calcium within the left anterior descend-
ing artery. The calcium is seen as bright white and is
highlighted by the arrow
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tool. However, the introduction of helical CT
systems in the late 1990s signaled themodern era
of cardiac CT with the creation of 16-slice
scanners, and consequently the opportunity for
clinical use of coronary CTA. Over the next few
years, the number of detectors increased to 64,
enabling greater clinical accuracy. This
availability of reproducible and diagnostically
sound images was heralded as a major
breakthrough, even outside the world of
medicine [34]. Although artefacts have not
been completely eliminated from cardiac CT,
the diagnostic performance of the standard
64-slice scanner is now well established [1, 2,
35]. In particular, it has demonstrated high
negative predictive value, ranging from 98% to
100% reliability, in excluding CAD [36–38]. The
ability of cardiac CT to detect significant
coronary stenoses has been validated against
conventional coronary angiography and
intravascular ultrasound [36–40]. The evolution
of this imaging technology has continued, with
the number of detectors increasing, resulting in
the wide availability of 128-, 256-, and
320-detector row scanners in clinical practice
[41, 42]. This progression is ongoing, with
640-detector row scanners now citing even less
radiation and scanning time, as well as improved
image quality [43].
Coronary CTA has the capacity to visualize
the coronary arteries without the risks associated
with invasive assessment. It can provide
comprehensive information regarding coronary
anatomy, the presence of obstructive and
non-obstructive CAD, and plaque
characteristics. This information can be used to
predict long-term outcomes, as both plaque
burden and non-obstructive disease have been
associated with adverse prognosis [44–46].
Conversely, the prognosis is excellent in the
absence of disease. A meta-analysis by Hulten
et al. [47], in which 9592 patients were evaluated
over a median follow-up of 20 months, found
that the absence of CAD on coronary CTA was
associated with a 0.17% annual rate of major
adverse cardiac events, compared to 8.8% among
patients with obstructive disease.
Coronary CTA is performed by the injection
of contrast into a peripheral vein, and images
are obtained when the contrast reaches the
coronary arteries (Fig. 3). The images are
Fig. 3 Comparison of coronary CTA and ICA.
a Coronary CTA showing a severe proximal left anterior
descending artery lesion. Note the lack of calcium in this
lesion. b ICA of the same patient. CTA computed
tomography angiography, ICA invasive coronary
angiography
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acquired relative to the patient’s
electrocardiogram (ECG) produced by surface
electrodes. The R–R interval of the ECG cycle is
typically divided into phases which involve
both the systolic and diastolic stages of the
cardiac cycle. For most persons, the maximum
relaxation of the heart is the best time to
acquire images, which is approximately 75%
along the R–R interval in mid-diastole. Methods
of image acquisition can be either retrospective
or prospective.
Retrospectively gated studies use X-ray
beams throughout the R–R interval. This was
traditionally associated with a high level of
radiation in full-dose retrospective studies
(Fig. 4). It is now common practice, however,
to use ECG dose modulation, which increases
the dose of radiation around 75% along the R–R
cycle in order to optimize the image without
constant high levels of radiation. Retrospective
studies use spiral scanning during table motion
and more traditional cone beam reconstruction
[48]. This offers the ability to reconstruct images
at various time points, potentially creating
greater diagnostic reassurance, and also the
ability to assess left ventricular function.
However, despite ECG dose modulation,
retrospective studies are still associated with a
higher radiation dose than prospective studies.
Prospective studies use forward prediction of
R wave timing, with no table motion during
imaging, and non-spiral acquisition [49]. Here,
Fig. 4 Diagram illustrating image acquisition (and thus
radiation exposure) during the different types of gating.
a Full-dose retrospective gating, with a constant high level
of radiation. b Electrocardiogram tube dose modulation,
with a constant low level of radiation, which is increased
during mid-diastole when the main part of the image is
acquired. c Prospective imaging during which the image
acquisition (and thus radiation exposure) occurs only at
pre-set intervals, again generally during mid-diastole.
Reproduced from Weustink and de Feyter [89]. This
article was published under the Creative Commons
Attribution Non-Commercial License
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essentially, the radiation/image acquisition is
turned on over several heartbeats when the
predefined point in the R–R cycle is detected,
which is generally 75% along the cycle. During
the rest of the ECG cycle, there is no image
acquisition or radiation exposure, resulting in a
smaller radiation dose compared to
retrospective studies. Prospective studies,
however, generally require a slower steady
constant heart rate, without which image
acquisition may not occur at every heartbeat.
Consequently, there may be a longer
acquisition time than in retrospective studies,
rendering it more vulnerable to heart rate and
breathing artefacts. Some newer CT machines
have the ability to increase the length of
radiation exposure so that image acquisition is
possible over a longer period of the R–R cycle.
This is called temporal padding, and it increases
the chance of finding the optimum timing of
minimal cardiac motion, and thus the best time
to acquire the image.
The potential limitations of coronary CTA
are numerous, and without careful and
experienced preparation to counter them, can
result in diagnostic uncertainty. Care in
patient selection is essential. Factors to
consider include body habitus, ability for
breath-hold, heart rate and rhythm, ability to
tolerate nitrates and rate-limiting medication,
and claustrophobia. During the scan process,
detailed instructions, practice of breathing
exercises, appropriate scan selection, and drug
administration are critical. Most operators
perform a CS before coronary CTA. A high
calcium load limits the ability of coronary CTA
to accuracy assess stenosis, with UK guidelines
suggesting that if a CS above 400 is obtained, a
coronary CTA should not be performed [3].
After the raw scan data have been acquired,
post-processing to remove abnormal heartbeats
can improve suboptimal images.
ANALYSIS OF PLAQUE
CHARACTERISTICS
Most acute coronary syndromes (ACS) are
caused by atherosclerotic plaque rupture,
causing sudden luminal thrombosis. The
prediction of specific plaques that may rupture
may be possible through coronary CTA plaque
analysis. In 2007, Motoyama et al. [50]
compared the plaque characteristics of patients
with ACS and stable angina, and concluded that
plaque characteristics associated with ACS
included positive vascular remodeling (PR),
low-attenuation plaque (LAP), non-calcified
plaque, and spotty calcification (SC), which
were not present in stable angina patients [50].
In further work by the same author, which
followed over 1000 patients who experienced
an ACS event post-coronary CTA, again found
that PR and LAP were predictors of ischemia
culprit lesions [51]. More recent work, also by
Motoyama et al. [52], with long-term follow-up
has once again suggested that patients with
high-risk features on CTA are likely to develop
ACS at a significantly higher rate. ACS occurred
in 23.0% of patients with two high-risk features,
10.7% of patients with one high risk feature,
1.6% of patients with no such features, and
0.6% of patients without any plaque (log-rank
P\0.0001) [52]. Another interesting plaque
characteristic is the napkin-ring sign (NRS),
which has been defined as a ring-like
peripheral higher attenuation of the
non-calcified portion of a coronary plaque
[53–55]. It indicates a rupture-prone plaque,
comprising a necrotic core covered by a thin
cap, also referred to as so-called thin-cap
fibroatheroma. The presence of a
fibroatheroma thin cap itself, however, cannot
be detected by coronary CTA due to limited
spatial resolution. The NRS has also been shown
to predict advanced lesions and ACS events [56,
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57]. Recent plaque analysis from the ROMICAT
(Rule Out Myocardial Infarction/Ischemia
Using Computer-Assisted Tomography) II
study has also demonstrated the importance of
ACS plaque characteristics such as PR, LAP, NRS,
and SC [58]. In patients presenting with acute
chest pain but negative initial ECG and
troponin, the presence of high-risk plaques on
coronary CTA is said to increase the likelihood
of ACS independent of significant CAD and
clinical risk assessment (age, sex, and number of
cardiovascular risk factors). These high-risk
plaque features may represent a way of
identifying patients most at risk, although
routine clinical assessment for them has not
yet been widely adopted, presumably due to the
difficulty of recognition and unclear
management. Nevertheless, their detection
offers hope for the identification and
management of ACS-prone patients.
CARDIAC COMPUTED
TOMOGRAPHY RADIATION
Although the diagnostic importance of CT is
undisputed, it does expose patients to radiation,
and thus the worry of malignancy [59]. In
general, CT is estimated to account for
approximately 50–70% of radiology-induced
radiation exposure overall, but only 15% of all
radiological examinations [60]. The number of
cardiac investigations using radiation is also
rising more rapidly than non-cardiac methods
[61]. The concern with radiation is particularly
high in cardiac patients given the potential
cumulative dose that repeated investigations
and therapy may produce. Radiation-induced
cancers cannot be distinguished from other
tumors, and consequently it is only by
epidemiological studies that the rate of
radiation-induced cancer can be detected. The
exact degree to which imaging radiation
exposure contributes to cancer remains
unknown [62], but research has suggested that
there is no increased cancer risk associated with
radiation exposure less than 20 mSv [63]. Levels
of radiation exposure from cardiac CT were
initially very high, with previous studies
quoting 55.6 mSv for a 16-slice scanner before
tube current modulation [64], but levels with
current scan technology have been cited as
sub-1 mSv [65].
The effect of radiation on human tissue can
be divided into two fundamental types:
non-stochastic (deterministic) and stochastic
effects. Deterministic effects are
dose-dependent, and occur only once a
threshold has been reached, with the severity
increasing with higher radiation dose. With
deterministic effects, the radiation itself causes
cell damage or death and thus functional
impairment of the tissue. These effects are
generally acute reactions [66], and include hair
loss, cataracts, skin burns, bone marrow
suppression, and diminished fertility.
Deterministic effects are not routinely
encountered in CT [67], but would be
expected at higher doses [68].
Stochastic effects are caused by the radiation
effect on cell division. As the word ‘‘stochastic’’
itself suggests, these effects are more random in
nature, likely the result of long-term events and
not a definite physical outcome. The higher the
dose absorbed, the higher the likelihood of an
event, although the dose received does not
predict the severity of the effect. As such,
stochastic effects are seen as independent of
the absorbed dose and follow a linear
no-threshold hypothesis. The two common
types of stochastic effects are malignancies and
heritable disease in offspring [62]. Cancers
post-exposure have a latency period thought
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to be approximately 5–10 years for solid tumors
and 2 years for leukemia [69].
For years, physicians have battled with the
issue of image quality versus radiation dose. The
past few years have witnessed unprecedented
advances in reducing radiation exposure, with
now standard practices such as retrospective
tube dose modulation and prospective axial
ECG-triggered gated image acquisition [70, 71].
Other methods include individualized protocol
selection, bismuth breast shields [35], and the
rebirth of iterative reconstruction [72–74].
LIMITATIONS OF CARDIAC
COMPUTED TOMOGRAPHY
In addition to radiation exposure, there are
several other limitations of cardiac CT. The
64-detector system takes a number of cardiac
cycles to acquire images, and as such is prone to
patient motion, arrhythmias, and patient
breath-hold failure, which can produce motion
artefacts and diagnostic uncertainty. Newer
256- and 320-detector scanners with faster
gantry rotation times, increased X-ray tube
power, and shorter scanning time have
improved, but not eliminated, this tendency
for artefacts. Other issues with cardiac CT
include the need for beta-blockers and
sublingual nitrate, potential allergic contrast
reactions, poor contrast filling of distal vessels
resulting in diagnostic uncertainty, and
contrast-induced renal toxicity.
In comparison to invasive angiography,
cardiac CT frequently overestimates the degree
of coronary stenosis. There are several reasons
for this. First, the presence of coronary calcium
can cause blooming artefacts, increasing the
perceived level of stenosis. Second, the
potential for motion artefacts can make lumen
assessment difficult. Third, inherent differences
exist between the two techniques, with invasive
angiography allowing the assessment of lumen
with precise classification of stenosis, while CT
is a tomographic approach that provides an
estimate of overall plaque burden [75]. The
accuracy of 64-slice CT was addressed in a
recent review which reported sensitivity of
89% (95% confidence interval [CI] 87–90),
specificity of 96% (95% CI 96–97), and
positive and negative predictive values of 78%
(95% CI 76–80) and 98% (95% CI 98–99),
respectively [75]. The excellent capacity of CT
for excluding disease means that it is
recommended in low- to medium-risk patients
[3–5].
THE FUTURE OF CARDIAC
COMPUTED TOMOGRAPHY
There is a large body of published studies
involving other uses of coronary CTA not
previously mentioned, such as in structural
heart disease intervention [76], bypass graft
assessment [77], congenital heart disease [78],
and acute chest pain [79, 80]. These
well-established indications, together with
UK, US, and European guidelines now
advocating its use [3–5], will ensure that
cardiac CT adoption will continue to grow.
Recent studies comparing cardiac CT with
functional tests have shown equivalent if not
better outcomes [81–83]. Moreover, the
number of cardiac CT studies published in
cardiology journals is also increasing, with CT
research surpassing nuclear cardiology reports
within the last 5 years [84].
Coronary CTA has also come to the fore as
having the potential to become a complete
imaging approach, with the ability to combine
anatomical and functional imaging techniques.
The potential for functional capacity has been
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seen in both CT perfusion imaging [85] and CT
fractional flow reserve (FFR) [86, 87]. The use of
FFR derived from CT is not yet widespread, but
initial studies have suggested that it provides
high diagnostic accuracy for hemodynamically
significant CAD in comparison to invasive FFR
[88]. The continued evolution of this approach
could enable the anatomical evaluation of
coronary arteries with simultaneous
physiologic assessment. As always, however,
this must be balanced against radiation
exposure, with the aim of providing a
reproducible, artefact-free, low-radiation scan
in a single heartbeat.
CONCLUSIONS
Cardiac CT is now an essential tool for
cardiologists. Although initial work was
clouded by the risk of high radiation exposure
and artefact-induced diagnostic uncertainty,
the capacity of CT technology has evolved to a
high degree of accuracy and a wide number of
indications. Its continued evolution holds the
potential of functional assessment in addition
to increased amounts of anatomical data about
coronary plaque. This paper highlights a brief
history of cardiac CT and some essential
knowledge for all users.
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